http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007014940-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc465575ae3ef6518e6ba9ea5b43e787
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d651a9c15b168cbde782bb3473618598
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e363a63c14c3363b6ac7924eb380e587
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c04169724cd35c8fd073360e4f5f5ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24d7130ea1184a65223e023c75d21ee6
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-227
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 2006-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88b1e98e0831ce61609a1075f07f2e0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_225667c8ed05d2760360211ff7b32d68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1002cb9588f47b0e7822ccb756792a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e6e316d254067a49350a6b195d4c19f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d4baec6b89ed66639066bc9bc19d499
publicationDate 2007-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007014940-A3
titleOfInvention Quinoline derivatives as antibacterical agents
abstract Use of a compound for the manufacture of a medicament for the treatment of a bacterial infection provided that the bacterial infection is other than a Mycobacterial infection, said compound being a compound of Formula (Ia) or (Ib), a pharmaceutically acceptable acid or base addition salt thereof, a quaternary amine thereof, a stereochemically isomeric form thereof, a tautomeric form thereof or a N-oxide form thereof, wherein R1 is hydrogen, halo, haloalkyl, cyano, hydroxy, Ar, Het, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di(Ar)alkyl; p is 1, 2 or 3; R2 is hydrogen; alkyl; hydroxy; mercapto; optionally substituted alkyloxy; alkyloxyalkyloxy; alkylthio; mono or di(alkyl)amino wherein alkyl may optionally be substituted; Ar; Het or a radical of Formula (ΙΙ); R3 is alkyl, Ar, Ar-alkyl, Het or Het-alkyl; q is zero, 1, 2, 3 or 4; X is a direct bond or CH2; R4 and R5 each independently are hydrogen, alkyl or benzyl; or R4 and R5 may be taken together including the N to which they are attached; R6 is hydrogen or a radical of Formula (III); R7 is hydrogen, alkyl, Ar or Het; R8 is hydrogen or alkyl; R9 is oxo ; or R8 and R9 together form the radical -CH=CH-N=.
priorityDate 2005-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004035569-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005070430-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0078748-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004011436-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0107432-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004089947-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9506047-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857

Total number of triples: 38.